Evotec SE (OTCMKTS:EVTCY – Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $3.17 and last traded at $3.19, with a volume of 82921 shares. The stock had previously closed at $3.31.
Evotec Stock Down 3.6 %
The firm has a market cap of $1.05 billion, a price-to-earnings ratio of 8.07 and a beta of 0.98. The stock has a 50-day moving average of $4.57 and a 200-day moving average of $5.94. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Jeff Brown’s Exegesis AI Stock Picks
- Insider Buying Explained: What Investors Need to Know
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
